Most notably, the expression of ABCB1, commonly known as P-glycoprotein (P-gp), and ABCG2, also known as BCRP or the breast cancer resistance protein, in tumor cells has been correlated to poor patients prognosis in numerous studies. Here, ABCG2 is linked to neoplasm.